These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 22373667)

  • 1. A novel "molecular tweezer" inhibitor of α-synuclein neurotoxicity in vitro and in vivo.
    Prabhudesai S; Sinha S; Attar A; Kotagiri A; Fitzmaurice AG; Lakshmanan R; Ivanova MI; Loo JA; Klärner FG; Schrader T; Stahl M; Bitan G; Bronstein JM
    Neurotherapeutics; 2012 Apr; 9(2):464-76. PubMed ID: 22373667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular tweezer CLR01 reduces aggregated, pathologic, and seeding-competent α-synuclein in experimental multiple system atrophy.
    Herrera-Vaquero M; Bouquio D; Kallab M; Biggs K; Nair G; Ochoa J; Heras-Garvin A; Heid C; Hadrovic I; Poewe W; Wenning GK; Klärner FG; Schrader T; Bitan G; Stefanova N
    Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165513. PubMed ID: 31319154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxicity of the Parkinson Disease-Associated Pesticide Ziram Is Synuclein-Dependent in Zebrafish Embryos.
    Lulla A; Barnhill L; Bitan G; Ivanova MI; Nguyen B; O'Donnell K; Stahl MC; Yamashiro C; Klärner FG; Schrader T; Sagasti A; Bronstein JM
    Environ Health Perspect; 2016 Nov; 124(11):1766-1775. PubMed ID: 27301718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Mutant αB Crystallin-Induced Protein Aggregation by a Molecular Tweezer.
    Xu N; Bitan G; Schrader T; Klärner FG; Osinska H; Robbins J
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-Synuclein.
    Richter F; Subramaniam SR; Magen I; Lee P; Hayes J; Attar A; Zhu C; Franich NR; Bove N; De La Rosa K; Kwong J; Klärner FG; Schrader T; Chesselet MF; Bitan G
    Neurotherapeutics; 2017 Oct; 14(4):1107-1119. PubMed ID: 28585223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential.
    Ferreira N; Gram H; Sorrentino ZA; Gregersen E; Schmidt SI; Reimer L; Betzer C; Perez-Gozalbo C; Beltoja M; Nagaraj M; Wang J; Nowak JS; Dong M; Willén K; Cholak E; Bjerregaard-Andersen K; Mendez N; Rabadia P; Shahnawaz M; Soto C; Otzen DE; Akbey Ü; Meyer M; Giasson BI; Romero-Ramos M; Jensen PH
    Acta Neuropathol; 2021 Jul; 142(1):87-115. PubMed ID: 33978813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts.
    Ardah MT; Ghanem SS; Abdulla SA; Lv G; Emara MM; Paleologou KE; Vaikath NN; Lu JH; Li M; Vekrellis K; Eliezer D; El-Agnaf OMA
    BMC Complement Med Ther; 2020 Mar; 20(1):73. PubMed ID: 32143619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson's disease.
    Bengoa-Vergniory N; Faggiani E; Ramos-Gonzalez P; Kirkiz E; Connor-Robson N; Brown LV; Siddique I; Li Z; Vingill S; Cioroch M; Cavaliere F; Threlfell S; Roberts B; Schrader T; Klärner FG; Cragg S; Dehay B; Bitan G; Matute C; Bezard E; Wade-Martins R
    Nat Commun; 2020 Sep; 11(1):4885. PubMed ID: 32985503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaempferol Has Potent Protective and Antifibrillogenic Effects for α-Synuclein Neurotoxicity In Vitro.
    Inden M; Takagi A; Kitai H; Ito T; Kurita H; Honda R; Kamatari YO; Nozaki S; Wen X; Hijioka M; Kitamura Y; Hozumi I
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Zebrafish Model to Measure Neuronal α-Synuclein Clearance In Vivo.
    Lopez A; Gorb A; Palha N; Fleming A; Rubinsztein DC
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The good and bad of therapeutic strategies that directly target α-synuclein.
    Longhena F; Faustini G; Brembati V; Pizzi M; Bellucci A
    IUBMB Life; 2020 Apr; 72(4):590-600. PubMed ID: 31693290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Molecular Tweezer Binding on α-Synuclein with Native Top-Down Mass Spectrometry and Ion Mobility-Mass Spectrometry Reveals a Mechanism for Aggregation Inhibition.
    Lantz C; Lopez J; Goring AK; Zenaidee MA; Biggs K; Whitelegge JP; Ogorzalek Loo RR; Klärner FG; Schrader T; Bitan G; Loo JA
    J Am Soc Mass Spectrom; 2023 Dec; 34(12):2739-2747. PubMed ID: 37936057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity.
    Qiao L; Hamamichi S; Caldwell KA; Caldwell GA; Yacoubian TA; Wilson S; Xie ZL; Speake LD; Parks R; Crabtree D; Liang Q; Crimmins S; Schneider L; Uchiyama Y; Iwatsubo T; Zhou Y; Peng L; Lu Y; Standaert DG; Walls KC; Shacka JJ; Roth KA; Zhang J
    Mol Brain; 2008 Nov; 1():17. PubMed ID: 19021916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibril growth and seeding capacity play key roles in α-synuclein-mediated apoptotic cell death.
    Mahul-Mellier AL; Vercruysse F; Maco B; Ait-Bouziad N; De Roo M; Muller D; Lashuel HA
    Cell Death Differ; 2015 Dec; 22(12):2107-22. PubMed ID: 26138444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
    Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
    J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models.
    Zhu Q; Zhuang XX; Chen JY; Yuan NN; Chen Y; Cai CZ; Tan JQ; Su HX; Lu JH
    Phytomedicine; 2021 Jul; 87():153578. PubMed ID: 34038839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mimicking phosphorylation at serine 87 inhibits the aggregation of human α-synuclein and protects against its toxicity in a rat model of Parkinson's disease.
    Oueslati A; Paleologou KE; Schneider BL; Aebischer P; Lashuel HA
    J Neurosci; 2012 Feb; 32(5):1536-44. PubMed ID: 22302797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrillar form of α-synuclein-specific scFv antibody inhibits α-synuclein seeds induced aggregation and toxicity.
    Gupta V; Salim S; Hmila I; Vaikath NN; Sudhakaran IP; Ghanem SS; Majbour NK; Abdulla SA; Emara MM; Abdesselem HB; Lukacsovich T; Erskine D; El-Agnaf OMA
    Sci Rep; 2020 May; 10(1):8137. PubMed ID: 32424162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct alpha-Synuclein species induced by seeding are selectively cleared by the Lysosome or the Proteasome in neuronally differentiated SH-SY5Y cells.
    Pantazopoulou M; Brembati V; Kanellidi A; Bousset L; Melki R; Stefanis L
    J Neurochem; 2021 Mar; 156(6):880-896. PubMed ID: 32869336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNAJB6 suppresses alpha-synuclein induced pathology in an animal model of Parkinson's disease.
    Arkan S; Ljungberg M; Kirik D; Hansen C
    Neurobiol Dis; 2021 Oct; 158():105477. PubMed ID: 34390836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.